News Release

Article

2009/2/2

PPMX received one billion yen from FUJIFILM in a third-party allocation of shares, and became a subsidiary company of Fuji Film.

2008/9/26

Perseus Proteomics starts selling “Human Pentraxin3/TSG-14 ELISA System” worldwide

2007/9/18

Perseus Proteomics, Inc. announces Collaborative Agreement for Research on "PTX3 as a cardiovascular risk predictor"

2007/5/15

Research progress regarding the "Vascular Injury marker Pentraxin 3(PTX3)" will be presented at Digestive Disease Week 2007

2007/4/25

Research progress regarding the "Vascular Injury marker Pentraxin 3(PTX3)" will be presented at The 51st Annual General Assembly and Scientific Meeting of Japan College of Rheumatology

2007/4/21

Development of Cystatin SN as a new diagnostic marker for colon cancer Reported at The 93rd Annual Meeting of the Japanese Society of Gastroenterology

2007/3/25

Research progress regarding the " Vascular Injury marker Pentraxin 3(PTX3)" will be presented at The American college of cardiology held on March 24-27th, 2007 in New Orleans.

2007/3/8

Research progress regarding the "Vascular Injury marker Pentraxin 3(PTX3)" will be presented at The 71st Annual Scientific Meeting of the Japanese Circulation Society held on March 15-17th, 2007 in Kobe.

2007/3/2

Our Collaboration Research results regarding "The Vascular Injury Marker PTX3" and "Research in Nuclear Hormone Receptors" will be presented at the 96th Annual Pathology Meeting.

2006/11/11

Our scientific article using Perseus Proteomics human ELISA system "Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris" was just published.

2006/10/12

Perseus Proteomics and Chugai Pharmaceutical reach purchase and sales agreement on glypican-3 therapeutic antibody.

2006/9/1

Perseus Proteomics Inc. Now Offers High Sensitivity Monoclonal Antibodies against All 48 of the Nuclear Hormone Receptors

2006/4/1

Perseus Proteomics Inc. announces its participation in the New Energy and Industrial Technology Development Organization (NEDO) government sponsored research project entitled "The Technical Development of New Functional Antibodies"

2006/4/1

Invited to Participate in NEDO Sponsored Government Project for the development of a Bionanochip for the Analysis of Protein Interactions Project (Focus 21)

2006/4/1

Perseus Proteomics Inc. Announces the Appointment of Dr. Toshiyo Tanaka and Dr. Patrick C. Reid to the Scientific Advisory Board.

2006/2/20

Fuji Photo Film Co., Ltd. Makes Equity Investment in Perseus Proteomics Inc.

2005/12/31

Perseus and CMIC announce the successful development of a novel diagnostic test kit capable of predicting atherosclerosis risk

2005/10/1

Offers full lineup of all 48 Nuclear Receptor antibodies

2005/10/1

Participation in National Institute of Biomedical Innovation Project

2005/8/1

Perseus Proteomics Inc. Announces the Appointment of Dr. Tatsuhiko Kodama (University of Tokyo, professor) and Kazuo Nakamura (CMIC Co., Ltd., Chaiman & CEO) to the Board of Directors. Dr. Hiroshi Matsushita assumes full-time position as company auditor.